Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Phase III results of olaparib for BRCA breast cancer

Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA

Phase III results of olaparib for BRCA breast cancer ( Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA )

Tivantinib as second line therapy for high-MET HCC

Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy

Tivantinib as second line therapy for high-MET HCC ( Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy )

3 or 6 months adjuvant oxaliplatin for colorectal cancer

Dr Tim Iveson - University Hospital Southampton, Salisbury, UK

3 or 6 months adjuvant oxaliplatin for colorectal cancer ( Dr Tim Iveson - University Hospital Southampton, Salisbury, UK )

No link between pregnancy and breast cancer relapse

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

No link between pregnancy and breast cancer relapse ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )

Cancer and caring in modern medicine

Prof Siddhartha Mukherjee - Columbia University Medical Center, New York, USA

Cancer and caring in modern medicine ( Prof Siddhartha Mukherjee - Columbia University Medical Center, New York, USA )

Pooled analysis of avelumab for metastatic urothelial carcinoma

Dr Andrea Apolo - National Cancer Institute, Bethesda, USA

Pooled analysis of avelumab for metastatic urothelial carcinoma ( Dr Andrea Apolo - National Cancer Institute, Bethesda, USA )

Cancer and living meaningfully: the CALM intervention

Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada

Cancer and living meaningfully: the CALM intervention ( Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada )

Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA

Larotrectinib shows durable efficacy across diverse paediatric and adult cancers ( Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA )

Routine genomic testing is feasible, but only a subset of patients benefit

Dr Olivier Trédan - Centre Léon Bérard, Lyon, France

Routine genomic testing is feasible, but only a subset of patients benefit ( Dr Olivier Trédan - Centre Léon Bérard, Lyon, France )

Molecular profiles and the future of adjuvant therapy

Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain

Molecular profiles and the future of adjuvant therapy ( Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain )

Pregnancy after breast cancer no associated with relapse risk

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

Pregnancy after breast cancer no associated with relapse risk ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )

Recent childhood cancer survivors face less chronic disease risk than previous...

Dr Todd Gibson - St Jude Children's Research Hospital, Memphis, USA

Recent childhood cancer survivors face less chronic disease risk than previous decades ( Dr Todd Gibson - St Jude Children's Research Hospital, Memphis, USA )

More from ecancer